| Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer D Zhang, Q Hu, X Liu, Y Ji, HP Chao, Y Liu, A Tracz, J Kirk, S Buonamici, ... Nature communications 11 (1), 2089, 2020 | 112 | 2020 |
| Telomerase protects werner syndrome lineage-specific stem cells from premature aging HH Cheung, X Liu, L Canterel-Thouennon, L Li, C Edmonson, ... Stem cell reports 2 (4), 534-546, 2014 | 103 | 2014 |
| Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor L Yang, X Liu, Z Lu, JYW Chan, LL Zhou, KP Fung, P Wu, S Wu Cancer Letters 298 (1), 128-138, 2010 | 90 | 2010 |
| Pheophorbide a based photodynamic therapy induces apoptosis via mitochondrial-mediated pathway in human uterine carcinosarcoma PMK Tang, XZ Liu, DM Zhang, WP Fong, KP Fung Cancer biology & therapy 8 (6), 533-539, 2009 | 81 | 2009 |
| Idiopathic autism: cellular and molecular phenotypes in pluripotent stem cell-derived neurons X Liu, E Campanac, HH Cheung, MN Ziats, L Canterel-Thouennon, ... Molecular neurobiology 54, 4507-4523, 2017 | 73 | 2017 |
| Polyphyllin D, a steroidal saponin from Paris polyphylla, inhibits endothelial cell functions in vitro and angiogenesis in zebrafish embryos in vivo JYW Chan, JCM Koon, X Liu, M Detmar, B Yu, SK Kong, KP Fung Journal of ethnopharmacology 137 (1), 64-69, 2011 | 73 | 2011 |
| Distribution of melamine in rat foetuses and neonates CY Chu, KO Chu, JYW Chan, XZ Liu, CS Ho, CK Wong, CM Lau, TL Ting, ... Toxicology letters 199 (3), 398-402, 2010 | 39 | 2010 |
| Apoptosis: Reprogramming and the fate of mature cells HH Cheung, X Liu, OM Rennert International Scholarly Research Notices 2012 (1), 685852, 2012 | 35 | 2012 |
| Inhibition of CDK9 activity compromises global splicing in prostate cancer cells Q Hu, N Poulose, S Girmay, A Helevä, D Doultsinos, A Gondane, ... RNA biology 18 (sup2), 722-729, 2021 | 20 | 2021 |
| MicroRNA-34a, prostate cancer stem cells, and therapeutic development W Li, X Liu, EM Dougherty, DG Tang Cancers 14 (18), 4538, 2022 | 18 | 2022 |
| Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness X Liu, W Li, I Puzanov, DW Goodrich, G Chatta, DG Tang Essays in Biochemistry 66 (4), 291-303, 2022 | 13 | 2022 |
| Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota … F Li, X Ling, S Chakraborty, C Fountzilas, J Wang, A Jamroze, X Liu, ... Journal of Experimental & Clinical Cancer Research 42 (1), 213, 2023 | 12 | 2023 |
| Reconstitution and Analyses of RNA Interactions with Eukaryotic Translation Initiation Factors and Ribosomal Preinitiation Complexes L Xiaozhuo, S Peter, J., S Ansuman, W Sarah, E. Methods, 2019 | 12 | 2019 |
| Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises W Li, Y Wang, X Liu, S Wu, M Wang, SG Turowski, JA Spernyak, A Tracz, ... International Journal of Molecular Sciences 25 (4), 2123, 2024 | 3 | 2024 |
| Deletion of the N-terminal Domain of Yeast Eukaryotic Initiation Factor 4B Reprograms Translation and Reduces Growth in Urea X Liu, H Moshiri, Q He, A Sahoo, SE Walker Frontiers in Molecular Biosciences, 1292, 2022 | 3 | 2022 |
| Dysregulated alternative splicing landscape identifies intron retention as a hallmark and spliceosome as a therapeutic vulnerability in aggressive prostate cancer D Zhang, Q Hu, Y Ji, HP Chao, A Tracz, J Kirk, S Buonamici, P Zhu, ... BioRxiv, 634402, 2019 | 2 | 2019 |
| Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells JS Kirk, J Wang, M Long, S Rosario, A Tracz, Y Ji, R Kumar, X Liu, ... Cell Stem Cell, 2024 | 1 | 2024 |
| Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance A Jamroze , X Liu, DG Tang Cancer Heterogeneity and Plasticity 1 (1), 0005, 2024 | | 2024 |
| Unmasking SMLR1: The hidden player in colorectal cancer's liver metastasis X Liu Cancer Heterogeneity and Plasticity 1 (1), 0002, 2024 | | 2024 |
| Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models L Yang, A Bhattacharya, D Peterson, Y Li, X Liu, E Marangoni, V Robila, ... Drug Resistance Updates 74, 101078, 2024 | | 2024 |
Dean G. TangRoswell Park Comprehensive Cancer Center在 roswellpark.org 的电子邮件经过验证
